1. Home
  2. FONR vs HYPD Comparison

FONR vs HYPD Comparison

Compare FONR & HYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FONR
  • HYPD
  • Stock Information
  • Founded
  • FONR 1978
  • HYPD 2014
  • Country
  • FONR United States
  • HYPD United States
  • Employees
  • FONR N/A
  • HYPD N/A
  • Industry
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HYPD
  • Sector
  • FONR Health Care
  • HYPD
  • Exchange
  • FONR Nasdaq
  • HYPD NYSE
  • Market Cap
  • FONR 77.1M
  • HYPD 73.3M
  • IPO Year
  • FONR 1987
  • HYPD 2018
  • Fundamental
  • Price
  • FONR $16.08
  • HYPD $13.11
  • Analyst Decision
  • FONR
  • HYPD
  • Analyst Count
  • FONR 0
  • HYPD 0
  • Target Price
  • FONR N/A
  • HYPD N/A
  • AVG Volume (30 Days)
  • FONR 31.0K
  • HYPD 4.8M
  • Earning Date
  • FONR 05-15-2025
  • HYPD 08-11-2025
  • Dividend Yield
  • FONR N/A
  • HYPD N/A
  • EPS Growth
  • FONR N/A
  • HYPD N/A
  • EPS
  • FONR 1.28
  • HYPD N/A
  • Revenue
  • FONR $103,018,089.00
  • HYPD $67,063.00
  • Revenue This Year
  • FONR N/A
  • HYPD N/A
  • Revenue Next Year
  • FONR N/A
  • HYPD N/A
  • P/E Ratio
  • FONR $12.47
  • HYPD N/A
  • Revenue Growth
  • FONR 0.29
  • HYPD 663.82
  • 52 Week Low
  • FONR $12.00
  • HYPD $0.85
  • 52 Week High
  • FONR $18.68
  • HYPD $124.80
  • Technical
  • Relative Strength Index (RSI)
  • FONR 64.00
  • HYPD N/A
  • Support Level
  • FONR $15.80
  • HYPD N/A
  • Resistance Level
  • FONR $16.30
  • HYPD N/A
  • Average True Range (ATR)
  • FONR 0.48
  • HYPD 0.00
  • MACD
  • FONR 0.02
  • HYPD 0.00
  • Stochastic Oscillator
  • FONR 73.61
  • HYPD 0.00

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About HYPD HYPERION DEFI INC

Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

Share on Social Networks: